These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21447768)

  • 21. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
    Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
    Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
    Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS
    Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study.
    Poveda MJ; Bernabeu A; Concepción L; Roa E; de Madaria E; Zapater P; Pérez-Mateo M; Jover R
    Neuroimage; 2010 Aug; 52(2):481-7. PubMed ID: 20451628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hepatic encephalopathy.
    Plauth M; Merli M; Kondrup J
    N Engl J Med; 1997 Dec; 337(26):1921-2. PubMed ID: 9417530
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
    Hamberg O
    Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dispelling myths in the treatment of hepatic encephalopathy.
    Shawcross D; Jalan R
    Lancet; 2005 Jan 29-Feb 4; 365(9457):431-3. PubMed ID: 15680459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary protein restriction as a treatment for slowing chronic kidney disease progression: the case against.
    Johnson DW
    Nephrology (Carlton); 2006 Feb; 11(1):58-62. PubMed ID: 16509934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of hepatic encephalopathy].
    Grüngreiff K
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(5):250-60. PubMed ID: 3150831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional intervention in uremia--myth or reality?
    Garneata L; Mircescu G
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S31-4. PubMed ID: 20797568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein restriction in the pre-end-stage renal disease (ESRD) patient: who, when, how, and the effect on subsequent ESRD outcome.
    Maroni BJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S100-6. PubMed ID: 11443755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nutritional therapy in patients with liver cirrhosis].
    Kondrup J; Nielsen K; Hamberg O
    Ugeskr Laeger; 1993 Jul; 155(29):2248-51. PubMed ID: 8328092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the metabolic complications of liver cirrhosis on dietary intake.
    Tözün N
    Med Sci Monit; 2000; 6(6):1223-6. PubMed ID: 11208483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical flicker frequency for quantification of low-grade hepatic encephalopathy.
    Kircheis G; Wettstein M; Timmermann L; Schnitzler A; Häussinger D
    Hepatology; 2002 Feb; 35(2):357-66. PubMed ID: 11826409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.
    Schäfer K; Winther MB; Ukida M; Leweling H; Reiter HJ; Bode JC
    Z Gastroenterol; 1981 Jul; 19(7):356-62. PubMed ID: 7293293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional support in the treatment of chronic hepatic encephalopathy.
    Milke García MP
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S45-9. PubMed ID: 22228881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo measurement of leucine metabolism with stable isotopes in normal subjects and in those with cirrhosis fed conventional and branched-chain amino acid-enriched diets.
    Millikan WJ; Henderson JM; Galloway JR; Warren WD; Matthews DE; McGhee A; Kutner MH
    Surgery; 1985 Sep; 98(3):405-13. PubMed ID: 4035563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is new about diet in hepatic encephalopathy.
    Merli M; Iebba V; Giusto M
    Metab Brain Dis; 2016 Dec; 31(6):1289-1294. PubMed ID: 26419384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
    Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.